Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?
Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Prisoners are usually locked in close quarters, which medical experts believe creates dangerous conditions that speed the spread of COVID-19. Prison personnel face the same problem.
Moleculin Biotech shares absolutely exploded on Wednesday after the company gave an update on its coronavirus treatment.
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Many people now worry that the visit to a doctor or hospital increases their risk of exposure to COVID-19. This could change the practice of medicine substantially.
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Immunomedics shares soared on Monday after the announcements that a late-stage breast cancer study was halted early and a new chief executive officer was named.
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within the sector.
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Doctors at a number of hospitals have been muzzled. Some have been threatened with being fired if they talk about what are often dire situations in the emergency rooms and intensive care units.
ElectroCore shares absolutely exploded on Friday after the company announced an update for its COVID-19 treatment.
A nurse employment crisis based on financial issues is about to begin in America and will get worse as the pandemic persists. Some nurses who practiced before the spread of COVID-19 will never come…
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up…
InflaRx shares jumped early on Wednesday after the company announced that it has enrolled its first patient into a clinical trial for the treatment of severe COVID-19-induced pneumonia.
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.